These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Management of direct action oral anticoagulants in the peri-operative period and invasive techniques]. Llau JV; Ferrandis R; Castillo J; de Andrés J; Gomar C; Gómez-Luque A; Hidalgo F; Torres LM; Rev Esp Anestesiol Reanim; 2012; 59(6):321-30. PubMed ID: 22633209 [TBL] [Abstract][Full Text] [Related]
3. [NOAC: Real-life data and the role of antidotes for the treatment of bleeding]. Darius H Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):99-104. PubMed ID: 28144725 [TBL] [Abstract][Full Text] [Related]
4. [Perioperative management of new oral anticoagulants]. Samama CM; Pernod G; Albaladejo P; Sie P; Presse Med; 2014 Jun; 43(6 Pt 1):637-44. PubMed ID: 24742616 [TBL] [Abstract][Full Text] [Related]
5. Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question. Douketis JD Mayo Clin Proc; 2008 Jun; 83(6):628-9. PubMed ID: 18533078 [No Abstract] [Full Text] [Related]
9. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study. Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338 [TBL] [Abstract][Full Text] [Related]
10. Improvement of the perioperative clinical management by implementation of integrated protocol of perioperative substitution of oral anticoagulants. Muñoz-Corsini L; Herrero-Martin S; de la Fuente-Tornero E; Amorós-Alfonso B; de la Lastra-Iglesias MA Rev Esp Anestesiol Reanim (Engl Ed); 2018 Apr; 65(4):238-240. PubMed ID: 29187300 [No Abstract] [Full Text] [Related]
12. To bridge or not to bridge, that is the question. Spyropoulos AC Intern Emerg Med; 2007 Jun; 2(2):145-7. PubMed ID: 17634821 [No Abstract] [Full Text] [Related]
13. The current status of bridging anticoagulation. Patel JP; Arya R Br J Haematol; 2014 Mar; 164(5):619-29. PubMed ID: 24224681 [TBL] [Abstract][Full Text] [Related]
15. Perioperative bridging with fondaparinux in a woman with antithrombin deficiency. Bauersachs R; Alban S Thromb Haemost; 2007 Mar; 97(3):498-9. PubMed ID: 17334522 [No Abstract] [Full Text] [Related]
16. Perioperative management of patients on chronic antithrombotic therapy. Ortel TL Hematology Am Soc Hematol Educ Program; 2012; 2012():529-35. PubMed ID: 23233630 [TBL] [Abstract][Full Text] [Related]
17. [Reversal strategies for non-vitamin K antagonist oral anticoagulants]. Larsen FU; Hvas AM; Grove EL Ugeskr Laeger; 2016 Oct; 178(40):. PubMed ID: 27697119 [TBL] [Abstract][Full Text] [Related]
18. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism. Beyer-Westendorf J; Ageno W Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150 [TBL] [Abstract][Full Text] [Related]
19. [Perioperative management of patients on NOACs]. Kelm C; Engels K Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):125-128. PubMed ID: 28083624 [TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulants and status of antidotes for the reversal of bleeding risk. Ebright J; Mousa SA Clin Appl Thromb Hemost; 2015 Mar; 21(2):105-14. PubMed ID: 25115762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]